Bioequivalence guideline for capecitabine to boost launch of Xeloda generic drugs

Korean makers of generic drugs are seeking the Korea Food and Drug Administration approval to sell a copy of Xeloda, whose active ingredient is capecitabine.

To this end, the KFDA has recently announced its new bioequivalence guideline for capecitabine.

The guideline describe the detailed bioequivalence testing procedures for capecitabine, such as testing agencies, number of subjects, inc...